Jazz Pharmaceuticals
JAZZ
#1410
Rank
โ‚ฌ13.47 B
Marketcap
209,86ย โ‚ฌ
Share price
-2.62%
Change (1 day)
37.55%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): 2,99ย โ‚ฌ

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 3,31ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,28ย โ‚ฌ a decrease over its 2024 EPS that were of 8,30ย โ‚ฌ.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)2,99ย โ‚ฌ-156.66%
2025-5,28ย โ‚ฌ-163.56%
20248,30ย โ‚ฌ39.08%
20235,97ย โ‚ฌ-285.03%
2022-3,23ย โ‚ฌ-34.2%
2021-4,90ย โ‚ฌ-224.83%
20203,93ย โ‚ฌ-53.25%
20198,40ย โ‚ฌ23.59%
20186,80ย โ‚ฌ-8.24%
20177,41ย โ‚ฌ23.74%
20165,99ย โ‚ฌ22.12%
20154,90ย โ‚ฌ478.49%
20140,85ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,78ย โ‚ฌ 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
7,56ย โ‚ฌ 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-0,98ย โ‚ฌ-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel